Annual D&A
$2.84 M
+$946.00 K+49.92%
December 31, 2023
Summary
- As of February 12, 2025, TRDA annual depreciation & amortization is $2.84 million, with the most recent change of +$946.00 thousand (+49.92%) on December 31, 2023.
- During the last 3 years, TRDA annual D&A has risen by +$2.52 million (+771.47%).
- TRDA annual D&A is now at all-time high.
Performance
TRDA Depreciation And Amortization Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Related metrics
Quarterly D&A
$937.00 K
+$27.00 K+2.97%
September 30, 2024
Summary
- As of February 12, 2025, TRDA quarterly depreciation & amortization is $937.00 thousand, with the most recent change of +$27.00 thousand (+2.97%) on September 30, 2024.
- Over the past year, TRDA quarterly D&A has increased by +$103.00 thousand (+12.35%).
- TRDA quarterly D&A is now at all-time high.
Performance
TRDA Quarterly D&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Related metrics
TTM D&A
$3.52 M
+$103.00 K+3.02%
September 30, 2024
Summary
- As of February 12, 2025, TRDA TTM depreciation & amortization is $3.52 million, with the most recent change of +$103.00 thousand (+3.02%) on September 30, 2024.
- Over the past year, TRDA TTM D&A has increased by +$886.00 thousand (+33.68%).
- TRDA TTM D&A is now at all-time high.
Performance
TRDA TTM D&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Related metrics
TRDA Depreciation And Amortization Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +49.9% | +12.3% | +33.7% |
| 3 y3 years | +771.5% | +78.1% | +85.6% |
| 5 y5 years | +2631.7% | +78.1% | +85.6% |
TRDA Depreciation And Amortization Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +154.3% | at high | +157.4% | at high | +214.9% |
| 5 y | 5-year | at high | +2631.7% | at high | +370.9% | at high | +1667.3% |
| alltime | all time | at high | +2631.7% | at high | +370.9% | at high | +1667.3% |
Entrada Therapeutics Depreciation And Amortization History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | $937.00 K(+3.0%) | $3.52 M(+3.0%) |
| Jun 2024 | - | $910.00 K(-2.6%) | $3.41 M(+5.6%) |
| Mar 2024 | - | $934.00 K(+26.9%) | $3.23 M(+13.8%) |
| Dec 2023 | $2.84 M(+49.9%) | $736.00 K(-11.8%) | $2.84 M(+8.0%) |
| Sep 2023 | - | $834.00 K(+14.2%) | $2.63 M(+13.7%) |
| Jun 2023 | - | $730.00 K(+34.9%) | $2.31 M(+13.0%) |
| Mar 2023 | - | $541.00 K(+2.9%) | $2.05 M(+8.0%) |
| Dec 2022 | $1.90 M | $526.00 K(+1.9%) | $1.90 M(+9.3%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2022 | - | $516.00 K(+11.4%) | $1.73 M(+14.1%) |
| Jun 2022 | - | $463.00 K(+18.7%) | $1.52 M(+16.1%) |
| Mar 2022 | - | $390.00 K(+7.1%) | $1.31 M(+17.1%) |
| Dec 2021 | $1.12 M(+242.6%) | $364.00 K(+20.5%) | $1.12 M(+48.3%) |
| Sep 2021 | - | $302.00 K(+19.8%) | $753.00 K(+67.0%) |
| Jun 2021 | - | $252.00 K(+26.6%) | $451.00 K(+126.6%) |
| Mar 2021 | - | $199.00 K | $199.00 K |
| Dec 2020 | $326.00 K(+213.5%) | - | - |
| Dec 2019 | $104.00 K | - | - |
FAQ
- What is Entrada Therapeutics annual depreciation & amortization?
- What is the all time high annual D&A for Entrada Therapeutics?
- What is Entrada Therapeutics annual D&A year-on-year change?
- What is Entrada Therapeutics quarterly depreciation & amortization?
- What is the all time high quarterly D&A for Entrada Therapeutics?
- What is Entrada Therapeutics quarterly D&A year-on-year change?
- What is Entrada Therapeutics TTM depreciation & amortization?
- What is the all time high TTM D&A for Entrada Therapeutics?
- What is Entrada Therapeutics TTM D&A year-on-year change?
What is Entrada Therapeutics annual depreciation & amortization?
The current annual D&A of TRDA is $2.84 M
What is the all time high annual D&A for Entrada Therapeutics?
Entrada Therapeutics all-time high annual depreciation & amortization is $2.84 M
What is Entrada Therapeutics annual D&A year-on-year change?
Over the past year, TRDA annual depreciation & amortization has changed by +$946.00 K (+49.92%)
What is Entrada Therapeutics quarterly depreciation & amortization?
The current quarterly D&A of TRDA is $937.00 K
What is the all time high quarterly D&A for Entrada Therapeutics?
Entrada Therapeutics all-time high quarterly depreciation & amortization is $937.00 K
What is Entrada Therapeutics quarterly D&A year-on-year change?
Over the past year, TRDA quarterly depreciation & amortization has changed by +$103.00 K (+12.35%)
What is Entrada Therapeutics TTM depreciation & amortization?
The current TTM D&A of TRDA is $3.52 M
What is the all time high TTM D&A for Entrada Therapeutics?
Entrada Therapeutics all-time high TTM depreciation & amortization is $3.52 M
What is Entrada Therapeutics TTM D&A year-on-year change?
Over the past year, TRDA TTM depreciation & amortization has changed by +$886.00 K (+33.68%)